Aids

The latest articles from AIDS Research and Therapy (ISSN 1742-6405) published by BioMed Central

Total news: 11
Last news: November 30, 1999 00:00:00

Latest HIV / AIDS News From Medical News Today.

Total news: 26
Last news: June 19, 2007 05:00:00

The mobilization of grassroots communities and the provision of condoms and antiretroviral drugs are beginning to slow the spread of Africas HIV/AIDS epidemic, according to a World Bank report released on Wednesday in Kigali, Rwanda, Reuters reports. The report examines the progress of the World Banks [click link for full article] - [Read more]

Tennessee Gov. Phil Bredesen (D) recently signed a bill (HB 1775) that would require people convicted of promoting commercial sex work to be tested for HIV, the Associated Press reports (Associated Press, 6/12). The House in April approved the bill, which was sponsored by Rep. Ulysses Jones (D). [click link for full article] - [Read more]

The New Jersey Department of Health and Senior Services is reviewing criteria from five cities in the state that applied to establish needle-exchange programs, and a decision is expected soon, health department spokesperson Tom Slater said on Tuesday, the [click link for full article] - [Read more]

Boehringer Ingelheim GmbH announced that it has begun to enroll patients in the SPRING study. The SPRING study will be one of the largest racially and gender diverse international studies of highly treatment-experienced HIV-1 infected patients. The trial will examine the safety, efficacy and pharmacokinetics of Aptivus® (tipranavir) in a racially diverse group of 200 female and 200 male treatment-experienced patients across eight countries in three continents. [click link for full article] - [Read more]

454 Life Sciences, a member of the Roche group, and a Yale School of Medicine researcher today announced that they have used the companys Genome Sequencer(TM) system to identify previously undetectable rare drug resistant HIV variants in samples from an earlier performed clinical trial. The work, presented today by Michael Kozal, M.D. [click link for full article] - [Read more]

Targeting HIV testing at high-risk groups and populations might be a more effective method of identifying people who are unaware of their HIV-positive status than conducting routine testing among all U.S. residents ages 13 to 64, David Holtgrave, a epidemiologist with the Johns Hopkins Bloomberg School of Public Health, writes in research article in the June 12 issue of PLoS Medicine, the [click link for full article] - [Read more]

The House Appropriations Committee recently approved a $21.4 billion appropriations bill that would lift a ban on city funding for needle-exchange programs in Washington, D.C., CongressDaily reports (Kivlan, CongressDaily, 6/12). The House Appropriations [click link for full article] - [Read more]

The Journal of the American Medical Association on Wednesday published two letters to the editor in response to a research letter in the March 13 issue of the journal that said eliminating written consent requirements for HIV tests might increase testing rates. Nicola Zetola of the [click link for full article] - [Read more]

Kate Heartfield, a member of the Ottawa Citizens editorial board, on Tuesday profiled United Nations Special Envoy for HIV/AIDS in Africa Elizabeth Mataka, who was appointed to the post in May by U.N. Secretary-General Ban Ki-moon. [click link for full article] - [Read more]

Higher immune cell counts in AIDS patients treated with highly active antiretroviral therapy (HAART) are associated a lower incidence of Kaposi sarcoma and non-Hodgkin lymphoma.AIDS patients are at high risk for Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer, but recent studies have found the incidence of Kaposi sarcoma and non-Hodgkin lymphoma has been declining in people with AIDS since the introduction of HAART in 1996. [click link for full article] - [Read more]

The owners and staff of 19 entertainment venues in Beijing frequented by men who have sex with men will distribute HIV prevention pamphlets and condoms at no cost in an effort to reduce the spread of HIV among the citys MSM population, Xinhua/Peoples Daily reports. The venues also will advise customers on safer-sex practices. [click link for full article] - [Read more]

Injection drug use in India might be more widespread than previously thought, which some health experts and advocates say could fuel the spread of HIV in the country, according to a UNAIDS-supported survey recently released by the Society for Promotion of Youth and Masses, Reuters reports. [click link for full article] - [Read more]

The US Centers for Disease Control and Prevention (CDC) recently advised health professionals to offer every patient aged 13-64 years "opt-out" HIV testing (i.e. testing without the need for risk assessment and counseling). [click link for full article] - [Read more]

The American Medical Student Association (AMSA) is disappointed to find that President Bushs proposal for the reauthorization of PEPFAR falls drastically short of the expectations of people with HIV, healthcare workers and activists. PEPFAR was introduced in 2003 with a 15 billion dollars pledge for AIDS relief in Africa and the Caribbean. On May 31, 2007, President Bush asked Congress to allocate an additional 30 billion dollars to sustain PEPFAR over the next 5 years. [click link for full article] - [Read more]

The Directors of Benitec (ASX: BLT) are delighted to announce the commencement of Benitecs first HIV human clinical trial in collaboration with City of Hope, a biomedical research and treatment center located just outside Los Angeles. This is Benitecs first human trial and will involve five HIV-1 infected adults 18-60 years old who suffer AIDS - related lymphoma. [click link for full article] - [Read more]

Boehringer Ingelheim Pharmaceuticals, Inc., makers of Aptivus(R) (tipranavir) capsules, announced today that it has begun to enroll patients in the SPRING study. The goal of the SPRING study, which will be conducted at 72 sites across eight countries, is to enroll 200 women and 200 men who are HIV-positive and highly treatment- experienced. [click link for full article] - [Read more]

Pharmasset, Inc. (Nasdaq: VRUS), a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, announced today that scientific data presentations about Clevudine and Racivir were made during the 16th International HIV Drug Resistance Workshop being held in St. Michael, Barbados from June 12-15, 2007. [click link for full article] - [Read more]

The "notion that clean needle-exchange programs are enabling and encouraging drug use is nonsense," Stephen Heath, public relations director for the Drug Policy Forum of Florida, writes in a New York Times letter to the editor in response to a recent Times [click link for full article] - [Read more]

Ugandan Minister of State and Gender Rukia Nakadama on Friday at the opening of a forum on gender and preventive technologies in the countrys capital, Kampala, called on leaders to strengthen efforts and increase resources to prevent the spread of HIV among women, the Monitor/AllAfrica.com reports. [click link for full article] - [Read more]

FDA "appears to have no evidence to justify its differential treatment" of people at increased risk of HIV who want to donate blood, a Washington Post editorial says (Washington Post, 6/12). [click link for full article] - [Read more]